Consolidated Interim Financial Statements
of InVision AG as of 30 September 2022
Consolidated Balance Sheet
Consolidated Statement of Comprehensive Income
Consolidated Cash Flow Statement
Consolidated Statement of Equity
Financial Summary
(in TEUR) | 9M 2022 | 9M 2021 | ∆* |
---|---|---|---|
injixo ARR (September) | 7,804 | 6,166 | +27% |
Total revenues | 10,724 | 10,096 | +6% |
EBIT | -2,329 | -356 | -554% |
as a % of revenues | -22% | -4% | -18 PP |
Consolidated result | -2,975 | -1,221 | -144% |
as a % of revenues | -28% | -12% | -16 PP |
Operating cash flow | -386 | 478 | -181% |
as a % of revenues | -4% | 5% | -9 PP |
Earnings per share (in EUR) | -1,33 | -0,57 | -133% |
(in TEUR) | 30 Sep 2022 | 31 Dec 2021 | ∆* |
---|---|---|---|
Balance sheet total | 21,196 | 19,988 | +6% |
Liquid funds | 8,711 | 6,338 | +37% |
Equity | 8,988 | 11,870 | -24% |
as a % of balance sheet total | 42% | 59% | -17 PP |
* The calculation of deviations from the previous year is based on non-rounded figures.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
InVision AG published this content on 03 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2022 08:14:02 UTC.